Patients admitted in the intensive care unit after solid organ or bone marrow transplantation: Retrospective cohort study

Table 3 Comparison of patients with and without sepsis, n (%)/median (25^th-75^th percentiles)

	Sepsis/ septic shock (n = 53)	Other diagnoses (n = 38)
Age at admission	55 (43.5-63.2)	57 (46-65)
Age at transplantation	50 (36.7-58.2)	54 (41-59)
Male gender	30 (56.6)	25 (65.8)
Comorbidites
Cardiovascular	32 (60.4)	24 (63.2)
Respiratory	5 (9.4)	8 (21.1)
Chronic kidney disease	18 (34.0)	16 (42.1)a
Chronic hemodialysis	4 (7.5)	7 (18.4)
Diabetes	10 (18.9)	6 (15.8)
Malignant disease	7 (13.2)	4 (10.5)
Respiratory support at admission	27 (50.9)	21 (55.3)
Vasoactive medication support at admission	26 (49.1)	6 (15.8)a
APACHE II	24.5 (19-28)	19.5 (15.5-23)a
SOFA	9 (7-12.5)	8 (5-9)a
Acute renal replacement therapy	35 (66.0)	16 (42.1)a
Mechanical ventilation	47 (88.7)	26 (68.4)a
Vasoactive medication support	47 (88.7)	18 (47.4)a
ICU LOS	8 (4-17)	5 (2-16)
Hospital LOS	30 (14.5-52.5)	19 (11-45)
ICU survival	8 (15.1)	16 (42.1)a
7 days survival	22 (41.5)	27 (71.1)a
28 days survival	15 (28.3)	21 (55.3)a
60 days survival	10 (18.9)	17 (44.7)a

^aP < 0.05.

APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; SOT: Solid organ transplantation; LOS: Length of stay; ICU: Intensive care unit.